(PKTX) Protokinetix has PR News!!! L'Oreal Independently Validates ProtoKinetix' AAGP(TM) Cosmetic Application
Wednesday 07/22/2009 8:36 AM ET - Businesswire
ProtoKinetix (PKTX) announces that L'Oreal (LOR) has applied for a patent using the ProtoKinetix' Anti-Aging Glyco Peptide (AAGP(TM)) family of molecules as the basis for a skin lightening agent.
This application had already been identified by PKTX as one of the many cosmetic applications included in its patents. If L'Oreal's patent application were to be successful, they would have to negotiate a license agreement with PKTX to commercialize the use of AAGP(TM) in any product.
Ross Senior, President and CEO of ProtoKinetix, states; "It is clear that this patent application by L'Oreal strongly supports the tremendous potential of AAGPs(TM) in a wide range of cosmetic applications including antiinflammation, anti-oxidation, UV protection, cell survival and anti-aging."
ProtoKinetix will be making additional announcements as this unique scenario unfolds.
About ProtoKinetix
ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP(TM)) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialog with major corporations and institutions who have contacted the Company about the broad range of applications for AAGP(TM) products. For more detailed information, visit our website at: www.protokinetix.com
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.
SOURCE: ProtoKinetix, Inc.
ProtoKinetix
Blair Henderson, 604-926-6627
